Yonsei University
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1885-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.yonsei.ac.kr
Assessment of Initial Efficacy and Safety of High Intensity Focused Ultrasound 'ExAblate 4000 Type 2' for Blood Brain Barrier Disruption in Patients With Alzheimer's Disease
Not Applicable
- Conditions
- Alzheimer Disease
- Interventions
- Device: transcranial magnetic resonance guided focused ultrasound BBB disruption
- First Posted Date
- 2020-08-25
- Last Posted Date
- 2020-08-25
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 6
- Registration Number
- NCT04526262
- Locations
- 🇰🇷
Department of Neurosurgery, Yonsei University College of Medici, Seoul, Korea, Republic of
Assessment of Tube Position According to the Changes of Neck Position Between Two Different Types of Nasotracheal Tubes
Not Applicable
Not yet recruiting
- Conditions
- Nasotracheal Intubation
- Interventions
- Device: MallinckrodtDevice: Portex
- First Posted Date
- 2020-08-05
- Last Posted Date
- 2020-08-05
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 40
- Registration Number
- NCT04499222
- Locations
- 🇰🇷
Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of
Validation of ERTugliflozin for Inhibiting Cardiac Fibrosis Using Cardiac MRI and Laboratory Parameters in Korean Heart Failure Patients With Nonischemic Cardiomyopathy(VERTICAL)
Phase 3
- Conditions
- Heart Failure With Nonischemic Cardiomyopathy
- Interventions
- Drug: Placebo
- First Posted Date
- 2020-07-29
- Last Posted Date
- 2020-08-07
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 52
- Registration Number
- NCT04490681
- Locations
- 🇰🇷
Severance Hospiatal, Seoul, Korea, Republic of
A Randomized, Placebo-controlled Clinical Trial of Teneligliptin as Quadruple Oral Combination Therapy for Type 2 DM After Failure of an Oral Triple Anti-diabetic Regimen
- First Posted Date
- 2020-06-24
- Last Posted Date
- 2021-06-09
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 100
- Registration Number
- NCT04446026
- Locations
- 🇰🇷
Yonsei Severance Hospital, Seoul, Korea, Republic of
The Effects of Perioperative PECS Block During Robotic Breast Surgery and Breast Reconstruction
Not Applicable
Completed
- Conditions
- Breast Neoplasm
- Interventions
- Procedure: pectoral nerve block
- First Posted Date
- 2020-06-22
- Last Posted Date
- 2021-11-17
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 30
- Registration Number
- NCT04440995
- Locations
- 🇰🇷
Yonsei Severance Hospital, Seoul, Korea, Republic of
The Influence of Head and Neck Position on the Cuff Pressure Using Nasotracheal Tube
Not Applicable
- Conditions
- Adult Patients Over 20 Years of Age Who Require Intubation of the Nasotracheal Tube to Undergo Oral and Maxillofacial Surgery Under General Anesthesia
- Interventions
- Procedure: Head extension positionProcedure: Head flexion positionProcedure: Head rotation positionProcedure: Neutral position
- First Posted Date
- 2020-06-22
- Last Posted Date
- 2020-09-23
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 50
- Registration Number
- NCT04441970
- Locations
- 🇰🇷
Yonsei Severance Hospital, Seoul, Korea, Republic of
The Efficacy and Safety of Non-vItamiN K antaGonist oraL Anticoagulants for intermEdiate Stroke Risk in Patients With Atrial Fibrillation (SINGLE-AF)
Phase 4
Recruiting
- Conditions
- Atrial Fibrillation Patients With Intermediate Stroke Risk
- Interventions
- Drug: Anticoagulation group(Apixaban group)
- First Posted Date
- 2020-06-18
- Last Posted Date
- 2025-02-10
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 1800
- Registration Number
- NCT04437654
- Locations
- 🇰🇷
Severance Cardiovascular Hospital Yonsei University, Seoul, Korea, Republic of
AnticoaguLation ONE Year After Ablation of Atrial Fibrillation in Patients With Atrial Fibrillation (ALONE AF Study)
Phase 4
Recruiting
- Conditions
- Atrial Fibrillation Patients With Moderate or High Stroke Risk Who Had Undergone Catheter Ablation of Atrial Fibrillation
- Interventions
- Drug: Anticoagulation group(Apixaban group)
- First Posted Date
- 2020-06-16
- Last Posted Date
- 2023-02-06
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 840
- Registration Number
- NCT04432220
- Locations
- 🇰🇷
Severance Cardiovascular Hospital Yonsei University, Seoul, Korea, Republic of
Compare the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy Versus Rosuvastatin Monotherapy in Korean Patients With Left Ventricular Diastolic Dysfunction and Hyperlipidemia
Phase 4
- Conditions
- Left Ventricular Diastolic DysfunctionHyperlipidemias
- Interventions
- Drug: Rosuvamibe 10/10
- First Posted Date
- 2020-06-16
- Last Posted Date
- 2021-01-15
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 200
- Registration Number
- NCT04433533
- Locations
- 🇰🇷
Yonsei Severance Hospital, Seoul, Korea, Republic of
Pericapsular Nerve Group (PENG) Block Versus Supra-inguinal Fascia Iliaca Compartment Block for Pain Management After Total Hip Arthroplasty: a Randomized Controlled Trial
Not Applicable
Completed
- Conditions
- Postoperative PainTotal Hip Arthroplasty
- Interventions
- Procedure: Pericapsular nerve group blockProcedure: Supra-inguinal fascia iliaca compartment block
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2021-07-20
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 58
- Registration Number
- NCT04426045
- Locations
- 🇰🇷
Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath